Lyme Disease and Leptospirosis Diseases Research – Immuno Technologies, Inc.
Our mission is to develop and license vaccines and immunodiagnostic assays to help mitigate the impact of these diseases in human and animal health. With our main focus in Lyme diseases and Leptospirosis, we develop and license vaccines and diagnostic assays to help mitigate the impact of these diseases on human and animal health.As our products mature from the laboratory to the next early stages of development, our long-term goal is to seek strategic alliances with partners who are capable of commercializing new biological products.
This company is:
Verified
OspA Recombinant Protein – Immuno Technologies, Inc.
Product Name OspA Reference Number BB-007 Description The OspA gene of Borrelia burgdorferi produces an outer surface protein, and is thought to play a major role in transmission of the spirochete causing Lyme Disease from the vector to the host. The OspA gene was obtained from Borrelia burgdorferi, strain B31. It was
Verified
OspC type B Recombinant Protein – Immuno Technologies, Inc.
Product Name OspC Type B Reference Number BB-014 Description OspC is an outer surface protein that is upregulated during transmission from tick to mammalian host and is crucial for the establishment of infection. OspC type B gene was PCR-amplified from group-specific OspC Borrelia burgdorferi human isolates and cloned
Verified
OspC Type C Recombinant Protein – Immuno Technologies, Inc.
Product Name OspC Type C Reference Number BB-015 Description OspC is an outer surface protein that is upregulated during transmission from tick to mammalian host and is crucial for the establishment of infection. OspC type C gene was PCR-amplified from group-specific OspC Borrelia burgdorferi human isolates and cloned
View all products
Keywords
Industries
Where is Immuno Technologies, Inc located?
The company Immuno Technologies, Inc is located in Memphis, Tennessee, United States. It's worth noting that the company may has more corporate locations
How many employees does Immuno Technologies, Inc approximately have?
As of the latest available information Immuno Technologies, Inc has around 1-10 employees worldwide.
When was Immuno Technologies, Inc founded?
Immuno Technologies, Inc was founded in 2012
In which industries does Immuno Technologies, Inc mainly work?
The company Immuno Technologies, Inc has it's main focus in the industries of Manufacturing, Biotechnology
United Biomedical,Inc
United States
11-50 Employees
1985
Kaytee Bio
Japan
Àvida Biotech
Spain
1-10 Employees
2016
Cambridge Technologies
United States
101-250 Employees
2015
DiaSorin
Italy
1001-5000 Employees
1968
Chemedimmune, Inc.
United States
1-10 Employees
2016
Phoenix Biotechnology, Inc.
United States
1-10 Employees
Fry Laboratories LLC
United States
1-10 Employees
2007
Topics which have been searched by others and may be interesting for you:
